Clinuvel Pharmaceuticals Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	36.14	28.02	35.2	31.89	121.51	82.69
Short-Term Investments	196.86	196.09	148.67	124.92	-	-
Cash & Short-Term Investments	233	224.11	183.87	156.81	121.51	82.69
Cash Growth	17.54%	21.88%	17.25%	29.05%	46.94%	23.89%
Accounts Receivable	16.58	24.17	25.01	20.64	15.9	15.81
Other Receivables	-	3.3	1.23	1.57	0.3	0.28
Receivables	16.58	27.46	26.24	22.21	16.2	16.09
Inventory	8.41	8.82	10.63	9.52	1.83	3.19
Prepaid Expenses	-	-	-	-	1.04	0.88
Other Current Assets	3.38	2.58	1.33	1.07	-	-
Total Current Assets	261.38	262.97	222.06	189.62	140.58	102.85
Property, Plant & Equipment	6.48	7.13	7.72	2.85	2.7	2.6
Long-Term Investments	0.22	0.21	0.13	-	-	-
Goodwill	-	-	-	-	0.19	0.19
Other Intangible Assets	0.19	0.19	0.19	0.19	-	-
Long-Term Deferred Tax Assets	1.42	1.26	1.02	1.06	0.48	2.93
Total Assets	269.7	271.75	231.12	193.71	143.95	108.57
Accounts Payable	10.68	2.55	2.35	2.79	0.26	4.66
Accrued Expenses	2.51	2.29	1.88	1.45	2.86	3.7
Current Portion of Leases	0.31	0.43	0.37	0.3	0.32	0.26
Current Income Taxes Payable	4.36	14.55	15.85	16.09	7.28	0.1
Other Current Liabilities	-	7.39	4.76	4.86	3.02	-
Total Current Liabilities	17.85	27.21	25.21	25.49	13.73	8.71
Long-Term Leases	0.02	0.1	0.51	0.7	0.94	1.05
Pension & Post-Retirement Benefits	-	0.13	0.08	0.06	0.03	0.01
Long-Term Deferred Tax Liabilities	2.62	3.42	2.23	2.76	3.62	-
Other Long-Term Liabilities	0.19	0.09	0.08	0.07	0.07	0.06
Total Liabilities	20.68	30.94	28.11	29.08	18.39	9.83
Common Stock	170.33	169.28	168.8	151.85	151.85	151.85
Retained Earnings	71.57	63.63	29.96	-9.77	-38.4	-58.13
Comprehensive Income & Other	7.12	7.9	4.25	22.56	12.11	5.02
Total Common Equity	249.02	240.81	203.01	164.63	125.56	98.74
Shareholders' Equity	249.02	240.81	203.01	164.63	125.56	98.74
Total Liabilities & Equity	269.7	271.75	231.12	193.71	143.95	108.57
Total Debt	0.32	0.53	0.88	1	1.26	1.3
Net Cash (Debt)	232.68	223.58	182.99	155.81	120.25	81.39
Net Cash Growth	17.81%	22.18%	17.44%	29.57%	47.75%	24.39%
Net Cash Per Share	4.60	4.44	3.59	3.01	2.32	1.59
Filing Date Shares Outstanding	50.16	50.12	50.08	49.41	49.41	49.41
Total Common Shares Outstanding	50.16	50.12	50.08	49.41	49.41	49.41
Working Capital	243.53	235.76	196.85	164.12	126.85	94.14
Book Value Per Share	4.96	4.80	4.05	3.33	2.54	2.00
Tangible Book Value	248.83	240.62	202.83	164.45	125.37	98.55
Tangible Book Value Per Share	4.96	4.80	4.05	3.33	2.54	1.99
Land	-	5.02	4.97	-	-	-
Machinery	-	2.19	1.94	1.53	1.33	0.82
Leasehold Improvements	-	1.99	1.99	1.89	1.25	1.25

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.